We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Retain Nordson Stock in Your Portfolio Now
Read MoreHide Full Article
Nordson Corporation (NDSN - Free Report) is poised to benefit from strong momentum in the Industrial Precision Solutions segment, driven by the solid demand for its nonwoven and industrial coating product lines. The growing demand for the company's packaging product lines across food and beverage, pharmaceutical and other consumer goods markets is driving the segment’s performance. Sales from this segment increased 6.8% year over year in fiscal 2024 (ended October 2024).
Also, stable demand for fluid solutions products, particularly in the biopharma end market, bodes well for the Medical and Fluid Solutions segment. Driven by strength across its businesses, the company expects sales to be in the band of $2.75-$2.87 billion in fiscal 2025 (ending October 2025), implying an increase of 4.5% at the midpoint on a year-over-year basis.
The company has been capitalizing on acquisitions by penetrating unexplored markets and expanding its product lines. For instance, in August 2024, it acquired Atrion Corporation’s three major businesses, Halkey Roberts, Atrion Medical and Quest Medical. The buyout will enable NDSN to expand its medical offerings in the infusion and cardiovascular therapies market.
Also, the ARAG Group buyout in August 2023 expanded its core capabilities in precision dispensing technology. Acquired assets boosted total revenues by 4.8% in fiscal 2024.
Nordson remains committed to rewarding shareholders through dividend payouts and share buybacks. In fiscal 2024, it paid out dividends of $161.4 million and bought back treasury shares worth $33.3 million. Also, in August 2024, the quarterly dividend was hiked 15% to 78 cents per share.
NDSN’s Price Performance
Image Source: Zacks Investment Research
In the past month, shares of this Zacks Rank #3 (Hold) company have gained 5.2% compared with the industry’s 2.2% growth.
However, NDSN has been grappling with weakness in the Advanced Technology Solutions segment. Lower demand for the company’s electronics dispense and test & inspection product lines remains a concern. This is reflected in the Advanced Technology Solutions segment’s revenues, which declined 11.6% in fiscal 2024. Also, supply-chain constraints, particularly in the medical device business, remain a concern for the company.
The company has also been dealing with the adverse impacts of rising operating costs and expenses. In the fourth quarter of fiscal 2024, its cost of sales recorded a year-over-year increase of 1.9% due to rising raw material costs. In the same quarter, the company’s selling and administrative expenses rose 12.5% year over year due to rising acquisition costs. This had an adverse impact on Nordson’s operating margin in the fiscal fourth quarter, which declined 170 basis points year over year to 24%.
Also, the high debt level remains a concern for Nordson. The company exited fiscal 2024 with a long-term debt of $2.1 billion, reflecting an increase of about 50% sequentially. The significant increase in debt level was primarily attributable to funds raised for acquisitions.
Key Picks
Some better-ranked companies from the same industry are discussed below.
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for Graham’s fiscal 2025 (ending March 2025) earnings has been stable.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). AIT delivered a trailing four-quarter average earnings surprise of 5%.
In the past 60 days, the consensus estimate for AIT’s fiscal 2025 (ending June 2025) earnings has inched up 0.1%.
Chart Industries (GTLS - Free Report) presently carries a Zacks Rank of 2. In the past 60 days, the consensus estimate for GTLS’ 2024 earnings has increased 1.2%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why You Should Retain Nordson Stock in Your Portfolio Now
Nordson Corporation (NDSN - Free Report) is poised to benefit from strong momentum in the Industrial Precision Solutions segment, driven by the solid demand for its nonwoven and industrial coating product lines. The growing demand for the company's packaging product lines across food and beverage, pharmaceutical and other consumer goods markets is driving the segment’s performance. Sales from this segment increased 6.8% year over year in fiscal 2024 (ended October 2024).
Also, stable demand for fluid solutions products, particularly in the biopharma end market, bodes well for the Medical and Fluid Solutions segment. Driven by strength across its businesses, the company expects sales to be in the band of $2.75-$2.87 billion in fiscal 2025 (ending October 2025), implying an increase of 4.5% at the midpoint on a year-over-year basis.
The company has been capitalizing on acquisitions by penetrating unexplored markets and expanding its product lines. For instance, in August 2024, it acquired Atrion Corporation’s three major businesses, Halkey Roberts, Atrion Medical and Quest Medical. The buyout will enable NDSN to expand its medical offerings in the infusion and cardiovascular therapies market.
Also, the ARAG Group buyout in August 2023 expanded its core capabilities in precision dispensing technology. Acquired assets boosted total revenues by 4.8% in fiscal 2024.
Nordson remains committed to rewarding shareholders through dividend payouts and share buybacks. In fiscal 2024, it paid out dividends of $161.4 million and bought back treasury shares worth $33.3 million. Also, in August 2024, the quarterly dividend was hiked 15% to 78 cents per share.
NDSN’s Price Performance
Image Source: Zacks Investment Research
In the past month, shares of this Zacks Rank #3 (Hold) company have gained 5.2% compared with the industry’s 2.2% growth.
However, NDSN has been grappling with weakness in the Advanced Technology Solutions segment. Lower demand for the company’s electronics dispense and test & inspection product lines remains a concern. This is reflected in the Advanced Technology Solutions segment’s revenues, which declined 11.6% in fiscal 2024. Also, supply-chain constraints, particularly in the medical device business, remain a concern for the company.
The company has also been dealing with the adverse impacts of rising operating costs and expenses. In the fourth quarter of fiscal 2024, its cost of sales recorded a year-over-year increase of 1.9% due to rising raw material costs. In the same quarter, the company’s selling and administrative expenses rose 12.5% year over year due to rising acquisition costs. This had an adverse impact on Nordson’s operating margin in the fiscal fourth quarter, which declined 170 basis points year over year to 24%.
Also, the high debt level remains a concern for Nordson. The company exited fiscal 2024 with a long-term debt of $2.1 billion, reflecting an increase of about 50% sequentially. The significant increase in debt level was primarily attributable to funds raised for acquisitions.
Key Picks
Some better-ranked companies from the same industry are discussed below.
Graham Corporation (GHM - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for Graham’s fiscal 2025 (ending March 2025) earnings has been stable.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). AIT delivered a trailing four-quarter average earnings surprise of 5%.
In the past 60 days, the consensus estimate for AIT’s fiscal 2025 (ending June 2025) earnings has inched up 0.1%.
Chart Industries (GTLS - Free Report) presently carries a Zacks Rank of 2. In the past 60 days, the consensus estimate for GTLS’ 2024 earnings has increased 1.2%.